# Botulinum Toxin Type A Versus Oral Ibuprofen for Bruxism

> **NCT07732751** · PHASE4 · COMPLETED · sponsor: **Cyprus Health and Social Sciences University** · enrollment: 40 (actual)

## Conditions studied

- Bruxism
- Myofascial Pain

## Interventions

- **DRUG:** Botulinum Toxin Type A 100U
- **DRUG:** Ibuprofen

## Key facts

- **NCT ID:** NCT07732751
- **Lead sponsor:** Cyprus Health and Social Sciences University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2026-02-06
- **Primary completion:** 2026-06-26
- **Final completion:** 2026-06-26
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2026-07-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07732751

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07732751, "Botulinum Toxin Type A Versus Oral Ibuprofen for Bruxism". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07732751. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*